Look at how low the short interest was back then relative to today, as we await the EMA decision within the next twelve months. And the institutional holdings were also a lot lower, as well.
I still believe that the PD short selling was baked in -- preplanned -- to kill any PD trial rally. It remains their modus operandi today.
If and when there's an EMA AD approval recommendation, Hoskuld can tell us how the shorts are coming out ahead on the rise of the share price, and you can raise the odds of an ultimate EU Commission approval all the way up to six percent.
Market Data 
Markets 
